Poincianamike, I was just going to ask if your buddy averaged down from .75...
This has been a tough ride. The biggest question has now been answered. Roth got this deal done already (today is the formal offer but it's done). There will be covenants and Jenny will effectively not be doing anything except 'placeholding' the CEO role.
It makes little sense to keep selling this lower by the big boys and now the run towards FDA approval begins.
Congrats to those who stayed in. I will be adding on this news.
You don't get rich by 'just' watching. I imagine ROTH will be putting their 'retail' clients on this as a Spec stock.
'p...mike' Thanks for sharing a segment of your journey and providing some insight into the experiences you and your golfing friends have encountered post "3rd reverse last Nov." Hopefully your friends, along with a few of us here who have experienced some major losses will have the opportunity to clawback a few dollars before another reverse split takes affect.
Regarding Simpson not being qualified to run the company, I'm beginning to realize that the majority of individuals in executive positions within Bio-techs and other ventures are all running on empty. I have said this a few times, in many instances "there is really no legitimate business. Instead, the stock IS the business, which is either an insider enrichment scheme or outright fraud." $DCTH is not unique in that respect.
As far as "Hitting the ball 240 with a draw...," definitely "...not bad for 66 year old!" Being only three years behind you, I can identify with your physical accomplishment. To that I say "Rock On!"
Hope you chime in a few more times as this debacle continues. Bring 'Benwha...' and his "Band of Merry Makers" along for the ride as well. We could all join "Kong Rides the Bomb."
News 
Market Data 
Discover 
